Health Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next bydigitalpapertown@gmail.comDecember 5, 2024
Health How we’re thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS bydigitalpapertown@gmail.comNovember 16, 2024
Top Stories Cramer’s favorite stock of earnings season so far gets new props from analysts bydigitalpapertown@gmail.comNovember 5, 2024
Health Jim Cramer: Abbott stock is ‘dirt cheap’ after a surprising legal win validates our conviction bydigitalpapertown@gmail.comNovember 1, 2024
Health GE Healthcare has been an under-the-radar winner — and a new catalyst just arrived bydigitalpapertown@gmail.comOctober 1, 2024
